Similar Search Results

Multiple criteria decision analysis for value based assessment of new medical technologies: a conceptual framework

Kanavos, Panos; Angelis, Aris - London School of Economics (LSE) - 2013

Assessing the value of new medical technologies may require new approaches that take into account a more comprehensive set of parameters than the incremental cost/QALY. It is argued that MCDA can fulfil this role and has the potential to be methodologically superior to the currently used...

Persistent link: https://www.econbiz.de/10010884583

Medicines in parallel trade in the European Union: a gravity specification

Costa-i-Font, Joan; Kanavos, Panos - London School of Economics (LSE) - 2007

While recent research has explored the phenomenon of drug parallel trade in regulated environments such as the European … is price differences across countries, the propagation mechanism lies in (a) the way drug prices are regulated across … drug prices are regulated. The implications that flow from our study are that a more flexible and competitive and less …

Persistent link: https://www.econbiz.de/10010745350

Is medicines parallel trade ‘regulatory arbitrage’?

Costa-i-Font, Joan - London School of Economics (LSE) - 2015

In the European Union, medicines are regulated products subject to both single market (e.g., regional exhaustion of property rights) and country specific health care regulations (e.g., medicines pricing). This gives rise to parallel trade (PT), a phenomenon that takes place when a patented...

Persistent link: https://www.econbiz.de/10011171762

Patents and the global diffusion of new drugs

Cockburn, Iain; Lanjouw, Jean O.; Schankerman, Mark - London School of Economics (LSE) - 2014

This paper studies how patent rights and price regulation affect how fast new drugs are launched in different countries, using newly constructed data on launches of 642 new drugs in 76 countries for the period 1983-2002, and information on the duration and content of patent and price control...

Persistent link: https://www.econbiz.de/10011126137

Advanced purchase commitments for a malaria vaccine: estimating costs and effectiveness

Berndt, Ernst R.; Glennerster, Rachel; Kremer, Michael R.; … - London School of Economics (LSE) - 2005

To overcome the problem of insufficient research and development (R&D) on vaccines for diseases concentrated in low-income countries, sponsors could commit to purchase viable vaccines if and when they are developed. One or more sponsors would commit to a minimum price that would be paid per...

Persistent link: https://www.econbiz.de/10011071268

How mental illness loses out in the NHS

London School of Economics (LSE) - 2012

Mental illness accounts for a massive share of the total burden of disease. Even when we include the burden of premature death mental illness accounts for 23% of the total burden of disease. Yet, despite the existence of cost-effective treatments, it receives only 13% of NHS health expenditure....

Persistent link: https://www.econbiz.de/10010884537

Medical technology as a key driver of rising health expenditures: disentangling the relationship

Sorenson, Corinna; Drummond, Michael; Bhuiyan Kahn, Beena - London School of Economics (LSE) - 2013

Health care spending has risen steadily in most countries, becoming a concern for decision-makers worldwide. Commentators often point to new medical technology as the key driver for burgeoning expenditures. This paper critically appraises this conjecture, based on an analysis of the existing...

Persistent link: https://www.econbiz.de/10010746236

Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines?

Srivastava, Divya; McGuire, Alistair - London School of Economics (LSE) - 2013

Access to medicines is an important health policy issue. This study analyses the demand for medicines in low-income countries from the perspective of the prices paid by public authorities. The analysis draws on World Health Organization (WHO) and Health Action International (HAI) 2006 data on...

Persistent link: https://www.econbiz.de/10010746512

Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, clus...

Henderson, Catherine; Knapp, Martin; Fernández, José-Luis - London School of Economics (LSE) - 2013

Objective: To examine the costs and cost effectiveness of telehealth in addition to standard support and treatment, compared with standard support and treatment. Design: Economic evaluation nested in a pragmatic, cluster randomised controlled trial. Setting: Community based telehealth...

Persistent link: https://www.econbiz.de/10011125884

Analysis of prices paid by low-income countries: how price sensitive is government demand for medicines?

Srivastava, Divya; McGuire, Alistair - London School of Economics (LSE) - 2014

Background:- Access to medicines is an important health policy issue. This paper considers demand structures in a selection of low-income countries from the perspective of public authorities as the evidence base is limited. Analysis of the demand for medicines in low-income countries is critical...

Persistent link: https://www.econbiz.de/10011125993